Increase your pipeline’s success rates and improve scalability by generating and activating biotech insights that support both early-stage and established companies.
Drawing from our comprehensive knowledge of the biotech landscape, and specialized expertise in rare disease markets, we equip our clients with tailored strategies to accelerate product development and optimize market access.
Access insights and approaches designed to best navigate the unique challenges of biotech and rare disease initiatives across our main areas of expertise.
KJT is more than just a vendor, they’re a partner. They always offer a tailored approach and are very responsive.
KJT helped figure out where we have been successful in influencing the market and pinpointed areas to focus on. We will be using suggestions that were provided.
When planning a real-world evidence (RWE) study, teams naturally focus on design,…
In pharmaceutical market research, one element remains consistently crucial: participant…
Publishing real-world evidence (RWE) research involves a comprehensive journey of strategic…
Understanding what goes on in the exam room between patients and HCPs remains a critical yet…
Artificial Intelligence is reshaping how life sciences organizations gather insights, understand…
Real-world evidence (RWE) is only as meaningful as the perspectives it includes. While healthcare…
Synthetic data is not new to market research, and the healthcare insights industry is starting to…
Digital twins are reshaping the way we generate insights across industries. In this webinar, we…
Understanding the realities, motivations, and emotions behind patient and caregiver experiences has…
Having spent 25 years in the consumer research sector (finance, CPG, retail, tech, etc), I am used…
